Exact Sciences Corporation

65.06+0.0900+0.14%Vol 1.35M1Y Perf 57.73%
Nov 29th, 2023 16:00 DELAYED
BID64.31 ASK69.00
Open66.02 Previous Close64.97
Pre-Market- After-Market-
 - -%  - -
Target Price
61.09 
Analyst Rating
Strong Buy 1.35
Potential %
-6.10 
Finscreener Ranking
★★★     49.58
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     45.74
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
     39.68
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
40.52 
Earnings Rating
Strong Buy
Market Cap11.77B 
Earnings Date
1st Nov 2023
Alpha-0.00 Standard Deviation0.16
Beta1.46 

Today's Price Range

64.9767.98

52W Range

40.73100.77

5 Year PE Ratio Range

-54.20-28.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
-0.49%
1 Month
10.16%
3 Months
-21.44%
6 Months
-19.82%
1 Year
57.73%
3 Years
-46.26%
5 Years
-16.57%
10 Years
429.80%

TickerPriceChg.Chg.%
EXAS65.060.09000.14
AAPL189.37-1.0300-0.54
GOOG136.40-2.2200-1.60
MSFT378.85-3.8500-1.01
XOM102.34-1.5600-1.50
WFC43.780.41000.95
JNJ152.110.48000.32
FB196.640.99000.51
GE118.860.01000.01
JPM154.320.78000.51
ValuationValueIndustryS&P 500US Markets
-11.50
2.70
6.83
364.30
-18.90
-1.71
-6.91
17.50
10.16B
Forward PE-54.09
PEG-0.22
Financial StrengthValueIndustryS&P 500US Markets
2.00
2.50
0.44
0.79
-54.30
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
72.80
-35.60
-26.00
-46.60
-32.38
RevenueValueIndustryS&P 500US Markets
1.53B
8.62
44.08
64.93
Earnings HistoryEstimateReportedSurprise %
Q03 2023-0.490.00100.00
Q02 2023-0.50-0.4510.00
Q01 2023-0.79-0.4246.84
Q04 2022-0.90-0.7220.00
Q03 2022-1.10-0.8423.64
Q02 2022-1.07-0.9412.15
Q01 2022-1.12-1.047.14
Q04 2021-0.91-1.28-40.66
Earnings Per EndEstimateRevision %Trend
12/2023 QR-0.531.85Positive
12/2023 FY-1.4822.11Positive
3/2024 QR-0.40-2.56Negative
12/2024 FY-1.224.69Positive
Next Report Date-
Estimated EPS Next Report-0.49
Estimates Count7
EPS Growth Next 5 Years %-
Volume Overview
Volume1.35M
Shares Outstanding180.85K
Shares Float178.50M
Trades Count26.33K
Dollar Volume89.16M
Avg. Volume1.19M
Avg. Weekly Volume687.65K
Avg. Monthly Volume1.51M
Avg. Quarterly Volume1.38M

Exact Sciences Corporation (NASDAQ: EXAS) stock closed at 65.06 per share at the end of the most recent trading day (a 0.14% change compared to the prior day closing price) with a volume of 1.35M shares and market capitalization of 11.77B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 5000 people. Exact Sciences Corporation CEO is Kevin T. Conroy.

The one-year performance of Exact Sciences Corporation stock is 57.73%, while year-to-date (YTD) performance is 31.41%. EXAS stock has a five-year performance of -16.57%. Its 52-week range is between 40.73 and 100.77, which gives EXAS stock a 52-week price range ratio of 40.52%

Exact Sciences Corporation currently has a PE ratio of -11.50, a price-to-book (PB) ratio of 2.70, a price-to-sale (PS) ratio of 6.83, a price to cashflow ratio of 364.30, a PEG ratio of -0.22, a ROA of -12.00%, a ROC of -12.34% and a ROE of -23.73%. The company’s profit margin is -32.38%, its EBITDA margin is -26.00%, and its revenue ttm is $1.53 Billion , which makes it $8.62 revenue per share.

Of the last four earnings reports from Exact Sciences Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.49 for the next earnings report. Exact Sciences Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Exact Sciences Corporation is Strong Buy (1.35), with a target price of $61.09, which is -6.10% compared to the current price. The earnings rating for Exact Sciences Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Exact Sciences Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Exact Sciences Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 15.93, ATR14 : 2.84, CCI20 : 68.38, Chaikin Money Flow : -0.10, MACD : 0.03, Money Flow Index : 39.74, ROC : 9.09, RSI : 50.97, STOCH (14,3) : 61.22, STOCH RSI : 0.04, UO : 38.32, Williams %R : -38.78), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Exact Sciences Corporation in the last 12-months were: Brian Baranick (Sold 0 shares of value $0 ), Brian Baranick (Sold 2 770 shares of value $170 643 ), Condella Sarah (Option Excercise at a value of $0), Condella Sarah (Sold 21 574 shares of value $1 562 325 ), Conroy Kevin (Option Excercise at a value of $0), Conroy Kevin (Sold 34 324 shares of value $2 186 371 ), Coward D. (Option Excercise at a value of $0), Coward D. (Sold 6 981 shares of value $436 430 ), Cunningham Everett (Sold 0 shares of value $0 ), Cunningham Everett (Sold 16 635 shares of value $1 089 808 ), Doyle James (Option Excercise at a value of $90 480), Doyle James (Sold 3 402 shares of value $288 135 ), Doyle James Edward (Sold 2 000 shares of value $194 840 ), Elliott Jeffrey (Option Excercise at a value of $0), Elliott Jeffrey (Sold 8 687 shares of value $545 550 ), Everett V. Cunningham (Option Excercise at a value of $0), Everett V. Cunningham (Sold 3 628 shares of value $224 972 ), Herriott James (Sold 1 300 shares of value $130 000 ), James E. Doyle (Option Excercise at a value of $90 480), James Herriott (Option Excercise at a value of $0), James Herriott (Sold 3 023 shares of value $185 652 ), Jeffrey T. Elliott (Option Excercise at a value of $0), Jeffrey T. Elliott (Sold 8 687 shares of value $545 550 ), Kevin T. Conroy (Option Excercise at a value of $0), Kevin T. Conroy (Sold 34 324 shares of value $2 186 371 ), Napier Katherine (Sold 3 027 shares of value $273 974 ), Orville Jacob (Option Excercise at a value of $0), Orville Jacob (Sold 20 496 shares of value $1 373 232 ), Sarah Condella (Option Excercise at a value of $0), Sarah Condella (Sold 8 987 shares of value $564 035 ), Scott D. Coward (Option Excercise at a value of $0), Scott D. Coward (Sold 6 981 shares of value $436 430 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
14 (82.35 %)
14 (82.35 %)
12 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (17.65 %)
3 (17.65 %)
4 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.35
Strong Buy
1.35
Strong Buy
1.50

Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in liquid biopsy (blood-based) cancer screening.

CEO: Kevin T. Conroy

Telephone: +1 608 284-5700

Address: 441 Charmany Drive, Madison 53719, WI, US

Number of employees: 5 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

56%44%

Bearish Bullish

58%42%

 

TipRanks News for EXAS

Tue, 28 Nov 2023 13:20 GMT Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Exact Sciences (EXAS) and Regeneron (REGN)

- TipRanks. All rights reserved.

Tue, 31 Oct 2023 10:55 GMT Exact Sciences (EXAS) Receives a Hold from Benchmark Co.

- TipRanks. All rights reserved.

Mon, 23 Oct 2023 13:10 GMT Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Elevance Health (ELV)

- TipRanks. All rights reserved.

Wed, 02 Aug 2023 14:40 GMT Analysts Top Healthcare Picks: Exact Sciences (EXAS), IQVIA Holdings (IQV)

- TipRanks. All rights reserved.

News

Stocktwits